316 related articles for article (PubMed ID: 18321097)
1. Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors.
Ji H; Stanton BZ; Igarashi J; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
J Am Chem Soc; 2008 Mar; 130(12):3900-14. PubMed ID: 18321097
[TBL] [Abstract][Full Text] [Related]
2. Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping.
Ji H; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
J Med Chem; 2009 Feb; 52(3):779-97. PubMed ID: 19125620
[TBL] [Abstract][Full Text] [Related]
3. Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases.
Silverman RB
Acc Chem Res; 2009 Mar; 42(3):439-51. PubMed ID: 19154146
[TBL] [Abstract][Full Text] [Related]
4. Potent and selective conformationally restricted neuronal nitric oxide synthase inhibitors.
Gómez-Vidal JA; Martásek P; Roman LJ; Silverman RB
J Med Chem; 2004 Jan; 47(3):703-10. PubMed ID: 14736250
[TBL] [Abstract][Full Text] [Related]
5. Structure-guided design of selective inhibitors of neuronal nitric oxide synthase.
Huang H; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
J Med Chem; 2013 Apr; 56(7):3024-32. PubMed ID: 23451760
[TBL] [Abstract][Full Text] [Related]
6. N(omega)-Nitroarginine-containing dipeptide amides. Potent and highly selective inhibitors of neuronal nitric oxide synthase.
Huang H; Martasek P; Roman LJ; Masters BS; Silverman RB
J Med Chem; 1999 Aug; 42(16):3147-53. PubMed ID: 10447959
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyethylene isosteres of selective neuronal nitric oxide synthase inhibitors.
Erdal EP; Martásek P; Roman LJ; Silverman RB
Bioorg Med Chem; 2007 Sep; 15(18):6096-108. PubMed ID: 17614291
[TBL] [Abstract][Full Text] [Related]
8. Pharmacophore and QSAR Modeling of Neuronal Nitric Oxide Synthase Ligands and Subsequent Validation and In Silico Search for New Scaffolds.
Suaifan G; Shehadeh M; Al-Ijel H; Al-Jamal KT; Taha M
Med Chem; 2016; 12(4):371-93. PubMed ID: 26427928
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of neuronal nitric oxide synthase by N omega-nitroarginine-and phenylalanine-containing dipeptides and dipeptide esters.
Silverman RB; Huang H; Marletta MA; Martasek P
J Med Chem; 1997 Aug; 40(18):2813-7. PubMed ID: 9288162
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design, synthesis, and biological evaluation of lipophilic-tailed monocationic inhibitors of neuronal nitric oxide synthase.
Xue F; Huang J; Ji H; Fang J; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
Bioorg Med Chem; 2010 Sep; 18(17):6526-37. PubMed ID: 20673724
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design and synthesis of N(omega)-nitro-L-arginine-containing peptidomimetics as selective inhibitors of neuronal nitric oxide synthase. Displacement of the heme structural water.
Seo J; Igarashi J; Li H; Martasek P; Roman LJ; Poulos TL; Silverman RB
J Med Chem; 2007 May; 50(9):2089-99. PubMed ID: 17425297
[TBL] [Abstract][Full Text] [Related]
12. Phenylpyrrole derivatives as neural and inducible nitric oxide synthase (nNOS and iNOS) inhibitors.
López Cara LC; Camacho ME; Carrión MD; Tapias V; Gallo MA; Escames G; Acuña-Castroviejo D; Espinosa A; Entrena A
Eur J Med Chem; 2009 Jun; 44(6):2655-66. PubMed ID: 19117642
[TBL] [Abstract][Full Text] [Related]
13. Structures of the neuronal and endothelial nitric oxide synthase heme domain with D-nitroarginine-containing dipeptide inhibitors bound.
Flinspach M; Li H; Jamal J; Yang W; Huang H; Silverman RB; Poulos TL
Biochemistry; 2004 May; 43(18):5181-7. PubMed ID: 15122883
[TBL] [Abstract][Full Text] [Related]
14. Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibition by Optimization of the 2-Aminopyridine-Based Scaffold with a Pyridine Linker.
Wang HY; Qin Y; Li H; Roman LJ; Martásek P; Poulos TL; Silverman RB
J Med Chem; 2016 May; 59(10):4913-25. PubMed ID: 27050842
[TBL] [Abstract][Full Text] [Related]
15. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
Hah JM; Martásek P; Roman LJ; Silverman RB
J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
[TBL] [Abstract][Full Text] [Related]
16. Selective monocationic inhibitors of neuronal nitric oxide synthase. Binding mode insights from molecular dynamics simulations.
Huang H; Ji H; Li H; Jing Q; Labby KJ; Martásek P; Roman LJ; Poulos TL; Silverman RB
J Am Chem Soc; 2012 Jul; 134(28):11559-72. PubMed ID: 22731813
[TBL] [Abstract][Full Text] [Related]
17. Recent advances toward improving the bioavailability of neuronal nitric oxide synthase inhibitors.
Huang H; Silverman RB
Curr Top Med Chem; 2013; 13(7):803-12. PubMed ID: 23578024
[TBL] [Abstract][Full Text] [Related]
18. Reduced amide bond peptidomimetics. (4S)-N-(4-amino-5-[aminoakyl]aminopentyl)-N'-nitroguanidines, potent and highly selective inhibitors of neuronal nitric oxide synthase.
Hah JM; Roman LJ; Martásek P; Silverman RB
J Med Chem; 2001 Aug; 44(16):2667-70. PubMed ID: 11472219
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of dipeptide amides containing N omega-nitroarginine and D-2,4-diaminobutyric acids as inhibitors of neuronal nitric oxide synthase.
Huang H; Martásek P; Roman LJ; Silverman RB
J Enzyme Inhib; 2001; 16(3):233-9. PubMed ID: 11697043
[TBL] [Abstract][Full Text] [Related]
20. Screening of novel and selective inhibitors for neuronal nitric oxide synthase (nNOS) via structure-based drug design techniques.
Boumezber S; Yelekçi K
J Biomol Struct Dyn; 2023 May; 41(8):3607-3629. PubMed ID: 35322764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
